IDENIX PHARMACEUTICALS INC·4

Mar 20, 10:40 AM ET

Fanning Paul 4

4 · IDENIX PHARMACEUTICALS INC · Filed Mar 20, 2012

Insider Transaction Report

Form 4
Period: 2012-03-16
Fanning Paul
SVP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2012-03-16$2.41/sh+30,000$72,30031,300 total
  • Sale

    Common Stock

    2012-03-16$11.04/sh30,000$331,2001,300 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2012-03-1630,0000 total
    Exercise: $2.41Exp: 2017-11-08Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]This option is fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION